---
title: "OPHLY.US (OPHLY.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/OPHLY.US/news.md"
symbol: "OPHLY.US"
name: "OPHLY.US"
parent: "https://longbridge.com/en/quote/OPHLY.US.md"
datetime: "2026-05-22T01:32:44.562Z"
locales:
  - [en](https://longbridge.com/en/quote/OPHLY.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/OPHLY.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/OPHLY.US/news.md)
---

# OPHLY.US (OPHLY.US) — Related News

### [Analyst Estimates: Here's What Brokers Think Of Ono Pharmaceutical Co., Ltd. (TSE:4528) After Its Yearly Report](https://longbridge.com/en/news/286163822.md)
*2026-05-12T22:01:14.000Z*
> Ono Pharmaceutical Co., Ltd. (TSE:4528) shares rose 7.1% to JP¥2,479 after its yearly report, with revenues of JP¥516b m

### [](https://longbridge.com/en/news/283698775.md)
*2026-04-22T15:41:37.000Z*
> Inhibrx Biosciences shares are trading higher after reports suggesting that the company may see takeover interest from p

### [ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso](https://longbridge.com/en/news/279072314.md)
*2026-03-13T16:30:30.000Z*
> ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso

### [17:00 ETCongruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs](https://longbridge.com/en/news/277524802.md)
*2026-03-02T22:00:47.000Z*
> Ono Pharmaceutical and Congruence Therapeutics have expanded their multi-target research partnership by adding two new p

### [Assessing Ono Pharmaceutical (TSE:4528) Valuation After Improved Nine Month Earnings](https://longbridge.com/en/news/275987048.md)
*2026-02-14T20:37:53.000Z*
> Ono Pharmaceutical (TSE:4528) reported strong nine-month earnings with sales of ¥397,036 million and net income of ¥68,9

### [Ono Pharmaceutical (OTCMKTS:OPHLF) Trading Up 14.5%  - Should You Buy?](https://longbridge.com/en/news/275938196.md)
*2026-02-13T19:22:36.000Z*
> Ono Pharmaceutical (OTCMKTS:OPHLF) saw a 14.5% increase in stock price, reaching $18.67, with a trading volume of 300 sh